Thermo Fisher Scientific Inc. (N:TMO)

Business Focus: Advanced Medical Equipment & Technology

Sector:  Healthcare Industry:  Advanced Medical Equipment & Technology
See Regulatory Filings on SEC
Company Contact
Address: 168 3rd Ave
WALTHAM MA 02451-7551
Tel: 1-781-6221111
IR: See website
Key People
Marc N. Casper
Chairman of the Board, President, Chief Executive Officer
Stephen Williamson
Chief Financial Officer, Senior Vice President
Mark P. Stevenson
Chief Operating Officer, Executive Vice President
Michel Lagarde
Executive Vice President
Michael A. Boxer
Senior Vice President, General Counsel
Syed A. Jafry
Senior Vice President and President, Regions
Peter E. Hornstra
Vice President, Chief Accounting Officer
Business Overview
Thermo Fisher Scientific Inc. develops, manufactures and sells a range of products. The Company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. It offers its products and services through various brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services. Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines. Analytical Instruments segment provides a broad offering of instruments, consumables, software and services that are used for a range of applications in the laboratory. Specialty Diagnostics segment offers a wide range of diagnostic test kits, reagents, culture media, instruments and associated products. Its Laboratory Products and Services segment offers products and solutions needed for the laboratory.
Financial Overview
For the six months ended 27 June 2020, Thermo Fisher Scientific Inc. revenues increased 6% to $13.15B. Net income before extraordinary items increased 2% to $1.94B. Revenues reflect Life Sciences Solutions segment increase of 32% to $4.38B, Laboratory products and services segment increase of 7% to $5.52B, Speciality Diagnostics segment increase of 2% to $1.95B, United States segment increase of 9% to $6.55B, Other segment increase of 10% to $5.54B.
Employees: 75,000 as of Dec 31, 2019
Reporting Currency: U.S. Dollars
Enterprise value: $179,953M as of Jun 27, 2020
Annual revenue (TTM): $26,248M as of Jun 27, 2020
EBITDA (TTM): $6,957M as of Jun 27, 2020
Net annual income (TTM): $3,734M as of Jun 27, 2020
Free cash flow (TTM): $3,929M as of Jun 27, 2020
Net Debt Last Fiscal Year: $15,495M as of Jun 27, 2020
Shares outstanding: 395,589,400 as of Jun 27, 2020
Index Membership: S&P 500
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.